These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7565486)

  • 1. Development of infants born to cocaine-abusing women: biologic/maternal influences.
    Howard J; Beckwith L; Espinosa M; Tyler R
    Neurotoxicol Teratol; 1995; 17(4):403-11. PubMed ID: 7565486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level of prenatal cocaine exposure and scores on the Bayley Scales of Infant Development: modifying effects of caregiver, early intervention, and birth weight.
    Frank DA; Jacobs RR; Beeghly M; Augustyn M; Bellinger D; Cabral H; Heeren T
    Pediatrics; 2002 Dec; 110(6):1143-52. PubMed ID: 12456912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early interactions between drug-involved mothers and infants. Within-group differences.
    Hofkosh D; Pringle JL; Wald HP; Switala J; Hinderliter SA; Hamel SC
    Arch Pediatr Adolesc Med; 1995 Jun; 149(6):665-72. PubMed ID: 7767424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopathology, mother-child interaction, and infant development: substance-abusing mothers and their offspring.
    Beckwith L; Howard J; Espinosa M; Tyler R
    Dev Psychopathol; 1999; 11(4):715-25. PubMed ID: 10624722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental outcomes and environmental correlates of very low birthweight, cocaine-exposed infants.
    Singer LT; Hawkins S; Huang J; Davillier M; Baley J
    Early Hum Dev; 2001 Sep; 64(2):91-103. PubMed ID: 11440822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-exposed infants and developmental outcome: effects of a home intervention and ongoing maternal drug use.
    Schuler ME; Nair P; Kettinger L
    Arch Pediatr Adolesc Med; 2003 Feb; 157(2):133-8. PubMed ID: 12580681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for disruption in primary caregiving among infants of substance abusing women.
    Nair P; Black MM; Schuler M; Keane V; Snow L; Rigney BA; Magder L
    Child Abuse Negl; 1997 Nov; 21(11):1039-51. PubMed ID: 9422825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perception of child vulnerability among mothers of former premature infants.
    Allen EC; Manuel JC; Legault C; Naughton MJ; Pivor C; O'Shea TM
    Pediatrics; 2004 Feb; 113(2):267-73. PubMed ID: 14754937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birth outcomes for infants of drug abusing mothers.
    Kaye K; Elkind L; Goldberg D; Tytun A
    N Y State J Med; 1989 May; 89(5):256-61. PubMed ID: 2733887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polydrug-using adolescent mothers and their infants receiving early intervention.
    Field TM; Scafidi F; Pickens J; Prodromidis M; Pelaez-Nogueras M; Torquati J; Wilcox H; Malphurs J; Schanberg S; Kuhn C
    Adolescence; 1998; 33(129):117-43. PubMed ID: 9583666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of maternal exposure to psychosocial job strain on pregnancy outcomes and child development.
    Larsen AD
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenting and early development among children of drug-abusing women: effects of home intervention.
    Black MM; Nair P; Kight C; Wachtel R; Roby P; Schuler M
    Pediatrics; 1994 Oct; 94(4 Pt 1):440-8. PubMed ID: 7936850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal ego development and mother-infant interaction in drug-abusing women.
    Fineman NR; Beckwith L; Howard J; Espinosa M
    J Subst Abuse Treat; 1997; 14(4):307-17. PubMed ID: 9368207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of auditory brain-stem response in full-term infants of cocaine-abusing mothers.
    Carzoli RP; Murphy SP; Hammer-Knisely J; Houy J
    Am J Dis Child; 1991 Sep; 145(9):1013-6. PubMed ID: 1877558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal cocaine exposures and dose-related cocaine effects on infant tone and behavior.
    Chiriboga CA; Kuhn L; Wasserman GA
    Neurotoxicol Teratol; 2007; 29(3):323-30. PubMed ID: 17234383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal nonnarcotic substance abuse during pregnancy: effects on infant development.
    Chasnoff IJ; Schnoll SH; Burns WJ; Burns K
    Neurobehav Toxicol Teratol; 1984; 6(4):277-80. PubMed ID: 6514088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal cocaine use and mother-infant interactions: Direct and moderated associations.
    Eiden RD; Schuetze P; Coles CD
    Neurotoxicol Teratol; 2011; 33(1):120-8. PubMed ID: 21256426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication.
    Lewis AJ; Galbally M; Opie G; Buist A
    Aust N Z J Psychiatry; 2010 May; 44(5):482-7. PubMed ID: 20397792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants.
    Lester BM; Tronick EZ; LaGasse L; Seifer R; Bauer CR; Shankaran S; Bada HS; Wright LL; Smeriglio VL; Lu J; Finnegan LP; Maza PL
    Pediatrics; 2002 Dec; 110(6):1182-92. PubMed ID: 12456917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The infants of adolescent mothers.
    Merritt TA; Lawrence RA; Naeye RL
    Pediatr Ann; 1980 Mar; 9(3):100-10. PubMed ID: 7360510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.